One Death and 61 cases of Monkeypox in Nigeria
The Nigeria Centre for Disease Control (NCDC) reported the first death from monkeypox, fourteen weeks after the first case was reported in Nigeria. The NCDC announced that there are 61 confirmed cases of this deadly disease. There has been a decline in the number of patients suffering from this disease in the past five weeks, which lead to deactivating the Emergency Operations Centre for monkeypox.
Nigeria witnessed a few different dangerous and preventable diseases such as Lassa fever, Cerebrospinal Meningitis, Cholera and SCM.
The first case of monkeypox in Nigeria was recorded on September 22, 2017, in the Niger Delta University Teaching Hospital, Okolobiri, Bayelsa State. By the end of October 2017, 43 people were affected by the dangerous disease.
Monkeypox is a rare disease that can be caused by infection with the Monkeypox virus which belongs to the same group of viruses that cause smallpox. African rodent species play a significant role in the transmission of the disease. The symptoms of the disease can be fever, vesicular skin rash, and painful jaw swelling. In the previous outbreaks around the world, this rare condition led to death in one in 10 people who suffered from the disease.
With no available treatment, protective vaccine or a cure, there is a need to raise awareness about the risk factors of monkeypox. The natural hosts of the virus are rodents, monkeys, squirrels, rats and other. Avoidance of any contact with body fluids and items of an infected person can prevent human-to-human transmission.
Cholera in Yemen
According to the Red Cross and the International Committee, the number of people who could be infected by the cholera virus is war-torn Yemen has reached a record high number of a million people.
The World Health Organisation warned that only in November this year approximately 2200 have died from the waterborne disease. Cholera in Yemen has spread quickly due to low sanitation conditions and deteriorating hygiene.
The emergency coordinator for Doctors Without Borders (MSF), Marc Poncin, said that the mortality rates are lowering in the past few months. However, the disease could spread again next year during the rainy season.
Experts predict that this could be the fastest spreading cholera epidemic since 1949, affecting one million people, including 600000 children. Until November, 4000 suspected cases were reported on a daily basis, including more than half among children who are younger than 18, while children under five account for one-quarter of all cases.
Tamer Kirolos, Save the Children’s country director for Yemen, spoke about the recent cholera outbreak saying that this is “what you get when a country is brought to its knees by conflict, when a healthcare system is on the brink of collapse, when its children are starving, and when its people are blocked from getting the medical treatment they need”.
The war in Yemen has lasted for more than two years, where there is a conflict between Houthi rebels and a Saudi-led coalition, causing a collapse of the public health system, internal displacement and leaving almost one million of people on the brink of famine.
Kmart Will Pay to Settle a Health Care Lawsuit
Federal officials announced that the Kmart Corporation would pay $32.3 million to settle a healthcare related case alleging its pharmacies overcharged private insurers and federal health care programs for generic prescription drugs.
Kmart Corp. withheld important information from Medicaid, Tricare, and Medicare Part D.
When a pharmacy is not entirely transparent about the pricing of their drugs, this can lead to federal health programs to overpay for a cheaper prescription drug. The settlement is also a reminder that there will be some consequences when a pharmacy is trying to increase the payment by hiding the actual price.
According to the lawsuit, Kmart sold a generic version of a prescription drug for only $5 to customers during its discount program, but then they filed for reimbursement from the US government for $152 for the same drug.
Larry Zoglin, an attorney at Washington, D.C.-based Phillips & Cohen said: “It is wrong for a pharmacy to charge government healthcare programs more than it charges cash-paying customers for the same prescription.”